Related Experiment Video
Updated: Oct 5, 2025

06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
2.9K
Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and
Li-Min Zhao1, Xie-Hui Chen1, Mei Qiu2
1Department of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Frontiers in Endocrinology
|January 27, 2022
Abstract
No abstract available in PubMed .
Keywords:
COVID- 19DPP4 (dipeptidyl peptidase 4) inhibitorsSGLT2Ideathglp1 agoniststype 2 diabetes mellitus
